ATVBJClub
PET Imaging in Pulmonary Hypertension.
Arteriosclerosis, Thrombosis, and Vascular Biology · · Review · Open access
van Leent, St Hillaire + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
[ 18 F]FDG PET shows a shift in right ventricular substrate use from fatty acid oxidation to glycolysis in pulmonary arterial hypertension, indicating metabolic stress and maladaptation.
- Why it matters: Early molecular changes in pulmonary arterial hypertension can precede overt right ventricular dysfunction, while echocardiography and cardiac magnetic resonance may miss these initial alterations.
- What they did: The review summarizes PET applications across pulmonary hypertension, highlighting [ 18 F]FDG PET metabolic imaging and first-in-human fibroblast activation protein inhibitor PET uptake in the right ventricle and pulmonary vasculature.
- The result: PET is positioned for early detection, phenotyping, and risk stratification in pulmonary hypertension, and may help monitor pulmonary vascular activity, right ventricular remodeling, and treatment response.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.